J. Safra Asset Management’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.8K Sell
693
-143
-17% -$3.31K ﹤0.01% 337
2026
Q1
$17.2K Buy
836
+565
+208% +$12.7K ﹤0.01% 320
2025
Q4
$6.42K Hold
271
﹤0.01% 397
2025
Q3
$6.75K Hold
271
﹤0.01% 285
2025
Q2
$6.23K Sell
271
-38
-12% -$880 ﹤0.01% 324
2025
Q1
$6.94K Buy
309
+249
+415% +$5.79K ﹤0.01% 302
2024
Q4
$1.17K Buy
60
+21
+54% +$416 ﹤0.01% 310
2024
Q3
$705 Buy
+39
New +$744 ﹤0.01% 281

Other funds holding PRVA

J. Safra Asset Management's PRVA Position: Q2 2026 in Review

J. Safra Asset Management reduced its Privia Health (PRVA) stake by 17% in Q2 2026, selling an estimated $3.31K and leaving 693 shares worth $17.8K. The position accounts for ﹤0.01% of the portfolio, ranked #337.

J. Safra Asset Management first reported a position in PRVA in Q3 2024 and has held it in 8 quarters since. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • J. Safra Asset Management held 693 shares of Privia Health worth $17.8K as of Q2 2026.
  • J. Safra Asset Management sold 143 Privia Health shares in Q2 2026, an estimated $3.31K.
  • Privia Health made up ﹤0.01% of J. Safra Asset Management's portfolio in Q2 2026, its #337 holding.
  • J. Safra Asset Management first reported a position in Privia Health in Q3 2024 and has held it in 8 quarters since.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.